西拉利珠单抗
Theralizumab | TGN1412 | TAB-08 | TABO8
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
1 mg 5 mg
Product Availability
3-5days
Price
$719.00
Member price
Product Availability
3-5days
Price
$1880.00
Member price
Quantity
- +
Product Overview
Product Name Theralizumab | TGN1412 | TAB-08 | TABO8
CAS906068-56-2
Storage condition store at -20°C | Shipping with blue ice.
Security information
Product details

Theralizumab (TGN1412) is a humanized lgG4 superagonistic anti-CD28 monoclonal antibody that directly stimulates T cells. Theralizumab can cause cytokine release syndrome (CRS). Theralizumab can be used for the research of rheumatoid arthritis.


Related
Sorry, no related items
History
Lenvatinib | E7080
Abciximab
Namilumab (Anti-CSF2 / GM-CSF)
Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1))
Theralizumab | TGN1412 | TAB-08 | TABO8
Opipramol (Synonyms: Ensidon; G-33040)
Pinobanksin 3-acetate ((2R,3R)-Pinobanksin 3-acetate; Pinobanksin 3-O-acetate; Pinobanksin acetate)
Anti-Human IL-23 Monoclonal Antibody(Guselkumab)
Alacizumab (Anti-VEGFR2 / KDR / CD309)
Benralizumab (Anti-IL-5Ra/ CD125)